This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dromer, F Articles by Dupont, B Search for Related Content PubMed PubMed Citation Articles by Dromer, F Articles by Dupont, B

Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.

Unité de Mycologie, Institut Pasteur, Paris, France.

ABSTRACT

The importance of epidemiological studies of cryptococcosis has increased since the beginning of the AIDS epidemic. Cryptococcus neoformans exists in two varieties defining four serotypes, Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). The varieties are easy to distinguish by their differences of growth on diagnostic media. We propose here an easy serotyping method combining diagnostic media and a direct immunofluorescence assay with one monoclonal antibody (E1) specific for cryptococcal polysaccharide. The method was validated by the blinded testing of four to five reference strains of each serotype. Immunofluorescence patterns were characteristic of a given serotype provided that the variety of the strain had been defined before. For C. neoformans var. neoformans, a bright, homogeneous staining with several cell aggregates was characteristics of serotype A, whereas only a few serotype D cells were positive. For C. neoformans var. gattii, a completely negative isolate was serotype C, whereas the population of serotype B included a majority of negative cells but also included positive cells with a speckled pattern. The method was then used to serotype 156 clinical isolates from France and isolates from areas where C. neoformans var. gattii was endemic before the AIDS epidemic (13 strains from Rwanda and Zaire and 5 strains from Australia). The specificity of E1 was defined by its reactivity with various Cryptococcus spp. and analyzed according to the described cryptococcal antigenic factors. We conclude from this study that E1 provides a rapid and reliable means to serotype multiple isolates of C. neoformans.

This article has been cited by other articles:

• Enache-Angoulvant, A., Chandenier, J., Symoens, F., Lacube, P., Bolognini, J., Douchet, C., Poirot, J. L., Hennequin, C. (2007). Molecular Identification of Cryptococcus neoformans Serotypes. J. Clin. Microbiol. 45: 1261-1265 [Abstract] [Full Text]  
• Dannaoui, E., Abdul, M., Arpin, M., Michel-Nguyen, A., Piens, M. A., Favel, A., Lortholary, O., Dromer, F., the French Cryptococcosis Study Group, (2006). Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.. Antimicrob. Agents Chemother. 50: 2464-2470 [Abstract] [Full Text]  
• Charlier, C., Chretien, F., Baudrimont, M., Mordelet, E., Lortholary, O., Dromer, F. (2005). Capsule Structure Changes Associated with Cryptococcus neoformans Crossing of the Blood-Brain Barrier. Am. J. Pathol. 166: 421-432 [Abstract] [Full Text]  
• Moyrand, F., Chang, Y. C., Himmelreich, U., Kwon-Chung, K. J., Janbon, G. (2004). Cas3p Belongs to a Seven-Member Family of Capsule Structure Designer Proteins. Eukaryot Cell 3: 1513-1524 [Abstract] [Full Text]  
• Moyrand, F., Janbon, G. (2004). UGD1, Encoding the Cryptococcus neoformans UDP-Glucose Dehydrogenase, Is Essential for Growth at 37{degrees}C and for Capsule Biosynthesis. Eukaryot Cell 3: 1601-1608 [Abstract] [Full Text]  
• Garcia-Rivera, J., Chang, Y. C., Kwon-Chung, K. J., Casadevall, A. (2004). Cryptococcus neoformans CAP59 (or Cap59p) Is Involved in the Extracellular Trafficking of Capsular Glucuronoxylomannan. Eukaryot Cell 3: 385-392 [Abstract] [Full Text]  
• Bauters, T. G. M., Swinne, D., Stove, V., Nelis, H. J. (2003). Detection of Single Cells of Cryptococcus neoformans in Clinical Samples by Solid-Phase Cytometry. J. Clin. Microbiol. 41: 1736-1737 [Abstract] [Full Text]  
• Boekhout, T., Theelen, B., Diaz, M., Fell, J. W., Hop, W. C. J., Abeln, E. C. A., Dromer, F., Meyer, W. (2001). Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 147: 891-907 [Abstract] [Full Text]  
• Garcia-Hermoso, D., Janbon, G., Dromer, F. (1999). Epidemiological Evidence for Dormant Cryptococcus neoformans Infection. J. Clin. Microbiol. 37: 3204-3209 [Abstract] [Full Text]  
• Guarro, J., Gene, J., Stchigel, A. M. (1999). Developments in Fungal Taxonomy. Clin. Microbiol. Rev. 12: 454-500 [Abstract] [Full Text]  
• Bertout, S., Renaud, F., Swinne, D., Mallié, M., Bastide, J.-M. (1999). Genetic Multilocus Studies of Different Strains of Cryptococcus neoformans: Taxonomy and Genetic Structure. J. Clin. Microbiol. 37: 715-720 [Abstract] [Full Text]  
• Franzot, S. P., Salkin, I. F., Casadevall, A. (1999). Cryptococcus neoformans var. grubii: Separate Varietal Status for Cryptococcus neoformans Serotype A Isolates. J. Clin. Microbiol. 37: 838-840 [Abstract] [Full Text]  
• Cleare, W., Casadevall, A. (1998). The Different Binding Patterns of Two Immunoglobulin M Monoclonal Antibodies to Cryptococcus neoformans Serotype A and D Strains Correlate with Serotype Classification and Differences in Functional Assays. CVI 5: 125-129 [Abstract] [Full Text]